News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Alnylam Pharmaceuticals to Cut 20-30 Pct Jobs After Novartis AG Ends Partnership
September 24, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sept 23 (Reuters) - Alnylam Pharmaceuticals Inc (ALNY.O) said it will be cutting 25-30 percent of its workforce due to the completion of a deal with Novartis (NOVN.VX).
Twitter
LinkedIn
Facebook
Email
Print
Job creations
MORE ON THIS TOPIC
Career Advice
The Top 12 Companies Hiring in Biopharma Now
September 4, 2025
·
1 min read
·
Angela Gabriel
Layoff Tracker
Novartis Continues Cutting Spree With 58 Sacked in New Jersey
September 3, 2025
·
195 min read
·
BioSpace Editorial Staff
Job Trends
Data Scientist Fourth Fastest-Growing U.S. Job, Says BLS
September 3, 2025
·
2 min read
·
Angela Gabriel
Interviews
Job Interviews That Needed a Do-Over
August 28, 2025
·
4 min read
·
Angela Gabriel
